Amedeo Smart

Free Medical Literature Service

 

Amedeo

Lung Cancer
  Free Subscription

Articles published in
Eur Respir J
    September 2025
  1. IMAI R, Fukui S, Inoue K
    Pirfenidone and lung cancer in idiopathic pulmonary fibrosis: mind the index date, detection bias and competing risks.
    Eur Respir J. 2025;66:2500453.
    >> Share

  2. YOON HY, Song JW
    Reply to: Pirfenidone and lung cancer in idiopathic pulmonary fibrosis: mind the index date, detection bias and competing risks.
    Eur Respir J. 2025;66:2501350.
    >> Share

    June 2025
  3. SHEIKH M, Weiderpass E
    Lung cancer screening in Europe: a golden opportunity to address tobacco use through scalable, WHO-guided cessation interventions.
    Eur Respir J. 2025;65:2500124.
    >> Share

    May 2025
  4. SELMAN M, Buendia-Roldan I, Pardo A
    Decoding the complexity: mechanistic insights into comorbidities in idiopathic pulmonary fibrosis.
    Eur Respir J. 2025;65:2402418.
    >> Share

    March 2025
  5. RATSIHORIMANANA R, Maitre T, Dusselier M, Triet Ngo M, et al
    Recurrent respiratory papillomatosis in adults with lower respiratory tract involvement: a retrospective study of the OrphaLung and GETIF networks.
    Eur Respir J. 2025;65:2400618.
    >> Share

    December 2024
  6. WENG C, Zhao Y, Song M, Shao Z, et al
    Mosaic loss of chromosome Y, tobacco smoking and risk of age-related lung diseases: insights from two prospective cohorts.
    Eur Respir J. 2024;64:2400968.
    >> Share

    November 2024
  7. YOON HY, Kim H, Bae Y, Song JW, et al
    Pirfenidone and risk of lung cancer development in IPF: a nationwide population-based study.
    Eur Respir J. 2024 Nov 7:2401484. doi: 10.1183/13993003.01484-2024.
    >> Share

    June 2024
  8. D'AMOURS MF, Wu FTH, Theisen-Lauk O, Chan EK, et al
    Surgically Resectable Non-Small Cell Lung Cancer: A Contemporary Approach.
    Eur Respir J. 2024 Jun 6:2400332. doi: 10.1183/13993003.00332-2024.
    >> Share

  9. SEIJO LM, Zulueta JJ
    The tip of the iceberg: a plethora of lung nodules in the general population.
    Eur Respir J. 2024;63:2400889.
    >> Share

  10. CAI J, Vonder M, Du Y, Pelgrim GJ, et al
    Who is at risk of lung nodules on low-dose CT in a Western country? A population-based approach.
    Eur Respir J. 2024;63:2301736.
    >> Share

  11. PORCEL JM
    Pleural mesothelioma: surgery questioned again?
    Eur Respir J. 2024;63:2400896.
    >> Share

  12. RASKIN J, Surmont V, Maat APWM, Yahia M, et al
    A randomised phase II study of extended pleurectomy/decortication preceded or followed by chemotherapy in patients with early-stage pleural mesothelioma: EORTC 1205.
    Eur Respir J. 2024;63:2302114.
    >> Share

    May 2024
  13. SESE L, Annesi-Maesano I
    Lung cancer and idiopathic pulmonary fibrosis: environmental exposures are the key.
    Eur Respir J. 2024;63:2400760.
    >> Share

    April 2024
  14. BRUDON A, Legendre M, Mageau A, Bermudez J, et al
    High risk of lung cancer in surfactant-related gene variant carriers.
    Eur Respir J. 2024 Apr 4:2301809. doi: 10.1183/13993003.01809-2023.
    >> Share

  15. LEWIS KE
    Smoking cessation at lung cancer screening: joining (life-saving) dots.
    Eur Respir J. 2024;63:2400550.
    >> Share

    March 2024
  16. YOON HY, Kim SY, Song JW
    Association Between High Levels of Nitrogen Dioxide and Increased Cumulative Incidence of Lung Cancer in Patients with Idiopathic Pulmonary Fibrosis.
    Eur Respir J. 2024 Mar 7:2301181. doi: 10.1183/13993003.01181-2023.
    >> Share

    February 2024

  17. "ERS/ESTS/ESTRO/ESR/ESTI/EFOMP statement on management of incidental findings from low dose CT screening for lung cancer." E.L. O'Dowd, I. Tietzova, E. Bartlett, et al. Eur Respir J 2023; 62: 2300533.
    Eur Respir J. 2024;63:2350533.
    >> Share

    January 2024
  18. OBACZ J, Valer JA, Nibhani R, Adams TS, et al
    Single-cell transcriptomic analysis of human pleura reveals stromal heterogeneity and informs in vitro models of mesothelioma.
    Eur Respir J. 2024;63:2300143.
    >> Share

    October 2023
  19. O'DOWD EL, Tietzova I, Bartlett E, Devaraj A, et al
    ERS/ESTS/ESTRO/ESR/ESTI/EFOMP statement on management of incidental findings from low dose CT screening for lung cancer.
    Eur Respir J. 2023 Oct 6:2300533. doi: 10.1183/13993003.00533-2023.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016